3-(3-(bromomethyl)phenyl)piperidine-2,6-dione

Catalog No. :
ACANJK274
CAS No. :
2903421-71-4
Molecular Formula :
C12H12BrNO2
Molecular Weight :
282.14

IUPAC Name:3-(3-(bromomethyl)phenyl)piperidine-2,6-dione

3-(3-(bromomethyl)phenyl)piperidine-2,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$250.00Login to see priceIn stockInquiry
100mg98%$450.00Login to see priceIn stockInquiry
250mg98%$900.00Login to see priceIn stockInquiry
500mg98%$1350.00Login to see priceIn stockInquiry
1g98%$2249.00Login to see priceInquiryInquiry
5g98%$6747.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-(bromomethyl)phenyl)piperidine-2,6-dione
IUPAC Name3-(3-(bromomethyl)phenyl)piperidine-2,6-dione
Molecular FormulaC12H12BrNO2
Molecular Weight282.14
SMILESO=C1CCC(C2=CC=CC(CBr)=C2)C(=O)N1
InChI KeyFWZRWPZDTYWYLD-UHFFFAOYSA-N
Synonym3-[3-(bromomethyl)phenyl]piperidine-2,6-dione;2,6-Piperidinedione, 3-[3-(bromomethyl)phenyl]-
CAS No.2903421-71-4

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P201-P202-P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACANJK274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACANJK274 route product structure diagram
    ACANJK2742903421-71-4 In Stock
Inquiry

2. ACANJK274 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACANJK274 route product structure diagram
    ACANJK2742903421-71-4 In Stock
Inquiry

Comments (0)